The short answer
Often, yes. Migraine with aura rules out estrogen birth control pills, but the British Menopause Society says it does not rule out hormone therapy. Estradiol through the skin, at the lowest dose that controls hot flashes, is usually preferred.
Why the pill and HRT are treated differently
| Combined birth control pill | Menopause hormone therapy | |
|---|---|---|
| The estrogen | Ethinylestradiol, at contraceptive doses [1] | Estradiol, at doses close to what the body made [1] |
| With aura | Category 4, unacceptable risk, in the CDC’s eligibility criteria [2] | Aura does not contraindicate it, says the British Menopause Society [3] |
| Stroke signal | About three times the ischemic stroke risk in women with migraine [2] | Patches at standard doses were not linked to stroke; pills were (rate ratio 1.28) [4] |
The difference is the hormone and the amount. Contraceptive pills use a strong synthetic estrogen to switch off ovulation. Menopause hormone therapy uses estradiol to replace part of what the ovaries stopped making. In a study of 15,710 strokes, low-dose patches were not linked to stroke (rate ratio 0.81) and higher-dose patches were (1.89), which is why the dose matters too [4].
What aura itself means for your heart and brain
Migraine with aura is a stroke risk factor on its own, with or without hormones. In the Women’s Health Study, 27,840 women aged 45 and older were followed for about 10 years. Those with active migraine with aura had about twice the risk of ischemic stroke (hazard ratio 1.91) and of major cardiovascular disease (2.15), or 18 extra major events per 10,000 women a year. Migraine without aura showed no added risk [5]. So a physician looks at your whole picture: blood pressure, smoking, cholesterol and clotting history, not just the headaches. Hormone therapy is not meant to add to that risk, which is why the choice of route and dose carries so much weight here.
What physicians usually choose
- Estradiol through the skin. A patch, gel or spray gives steadier levels than a pill, and the British Menopause Society prefers it where possible [3].
- The lowest dose that controls hot flashes. High doses can bring more headaches and migraine [3].
- A steady progestogen. Cyclical progestogens can worsen migraine, so a continuous plan or a levonorgestrel IUD is preferred [1]. See progesterone.
- A non-hormonal option if hormones are not right. Escitalopram or venlafaxine can help both migraine and hot flashes [3].
- Vaginal estrogen for dryness on its own. It acts locally, and the low-dose forms keep blood estradiol in the postmenopausal range [6]. See vaginal estrogen.
Questions your physician will ask
- What your aura looks like, how long it lasts, and whether it has changed recently.
- How often you get migraines now, and whether they cluster around your periods.
- Your blood pressure, whether you smoke, and any history of stroke, mini-stroke, heart attack or blood clots. The CDC’s birth control ratings assume none of those other stroke risks are present [2].
- Every medicine you take for migraine, including any you take to prevent attacks.
Starting low and adjusting is the usual approach: your physician begins with a low dose through the skin and changes it only if hot flashes persist. A simple headache diary over the first months helps both of you see whether anything has changed. MacGregor’s review makes the same point from the other side: using only the lowest skin dose needed to control hot flashes keeps the risk down [1].
This applies to
- Women with a history of migraine with aura who now have hot flashes or night sweats
- Women whose migraines change around their periods in perimenopause
This does not apply to
- Women who also had a stroke, a mini-stroke or a heart attack: estrogen labels rule hormone therapy out [7]
- Anyone with a first-ever aura, or an aura unlike their usual one, which needs a doctor in person
Read more about the forms on the estradiol page and every option on the menopause care page. Blood pressure and smoking change the same stroke equation: see HRT with high blood pressure and HRT if you smoke.
VevaMD is a technology company, not a medical provider. Educational content only, not medical advice. A US-licensed physician decides whether any treatment fits you, and a prescription is not guaranteed.
Sources
- MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reprod Health. 2018;24(1):11-18. Checked October 23, 2026.
- Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Appendices (classifications). Checked October 23, 2026.
- MacGregor EA, British Menopause Society medical advisory council. Tool for clinicians: migraine and HRT. British Menopause Society, reviewed April 2026. Checked October 23, 2026.
- Renoux C, Dell’aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ. 2010;340:c2519. Checked October 23, 2026.
- Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296(3):283-291. Checked October 23, 2026.
- The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976-992. Checked October 23, 2026.
- Divigel® (estradiol gel) prescribing information, revised February 2026. DailyMed. Checked October 23, 2026.